# Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial

> **NCT00139386** · PHASE4 · COMPLETED · sponsor: **Kumamoto University** · enrollment: 1119 (actual)

## Conditions studied

- Hypertension
- Coronary Artery Disease

## Interventions

- **DRUG:** Candesartan

## Key facts

- **NCT ID:** NCT00139386
- **Lead sponsor:** Kumamoto University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2009-04
- **Final completion:** 2012-04
- **Target enrollment:** 1119 (ACTUAL)
- **Last updated:** 2013-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00139386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00139386, "Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00139386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*